Synopsis: Among HIV-seropositive women, bacterial vaginosis was not associated with an increased risk of HSIL or cervical lesion progression. Results: Among 1,954 HIV-seropositive women, the baseline prevalence of HSIL was 17%. BV prevalence was high (54%) and showed no association with prevalent HSIL (adjusted prevalence ratio: 1.12, 95% CI: 0.92, 1.35) nor with cervical lesion progression at follow-up visit (N=503) (adjusted rate ratio: 1.00, 95% CI: 0.65, 1.53).
INTRODUCTION
In 2008, an estimated 16 million women were living with HIV infection worldwide, the majority of which occurred in less-developed countries [1] . In South Africa, the 2008 estimated prevalence of HIV infection in the general population was 11%. An estimated 60% of those cases were in women, with HIV prevalence as high as 33% among women aged 20-34 years [2] . Regardless of HIV status, cervical cancer is the leading cause of cancer in African women, and the second most common in South African women [3] . Moreover, HIV-related immunosuppression is associated with a higher prevalence and incidence of precancerous cervical lesions as well as invasive cervical cancer [4] . The high prevalence of HIV in South African women combined with the high prevalence of precancerous high grade cervical lesions underscores the need to better understand the etiology of cervical cancer in this high-risk population.
Human papillomavirus (HPV) infection is well-documented as the central causal agent of cervical cancer. Most women infected with high risk HPV types, however, do not develop high grade cervical lesions and cancer [5] . Other factors acting in conjunction with HPV infection are likely involved in promoting the oncogenic capabilities of HPV, leading to the development of cancer. Coinfection of HPV with bacterial vaginosis (BV) has been suggested to advance this process and, for more than 25 years, has been considered a possible risk factor for cervical cancer development [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] .
Only a few studies, however, have investigated the relationship between BV and cervical neoplasia in an HIV-seropositive study population, with inconsistent results [10, 16] .
We therefore present here results of the association between BV and high grade squamous intra-epithelial lesions in a large survey of HIV-seropositive women from South Africa. There were two main analyses. First, we assessed the cross-sectional association of BV and HSIL+ status using prevalence ratios (PRs) and corresponding 95% confidence intervals (CIs).
METHODS

Study
Prevalence ratios were estimated with multivariable log-binomial regression.
Second we assessed the effect of baseline BV on rate of any cervical lesion progression (from negative to LSIL, negative to HSIL+ or from LSIL to HSIL+) by first follow-up visit. In addition, we assessed the effect of BV at baseline and at first follow-up visit, indicative of persistent BV, on cervical lesion progression. Progression analysis was restricted to women who were HSIL-negative at baseline, and to women whose first follow-up visit was at least six months after baseline; this latter condition was employed to exclude apparent progressions which were more likely to be measurement error, as insufficient time had passed for a true progression to occur. We estimated adjusted incidence rate ratios (IRRs) and 95% CIs using Poisson regression with the log of follow-up time (time between visits) as the offset.
In both analyses, we identified potential confounding variables using directed acyclic graphs informed by literature. Covariates included CD4 count (categorized as <200; 200-500; and >500 In both regression modeling processes, covariates were maintained in the models through backwards elimination based on a likelihood ratio test p-value of <0.1, although age and CD4 count were maintained in all models. Less than 4% of the study population had missing values for one or more covariates in the full multivariate model, and thus were excluded from final analyses. All analyses were performed using SAS 9.2 (SAS Corporation, Cary, NC).
RESULTS
A total of 1,954 women with baseline cytology contributed to analysis. Of these women, 1,063 (54%) had BV at baseline ( The overall baseline prevalence of cervical lesions was 15% for LSIL and 17% for HSIL However, these later results were statistically insignificant and less precise. A high prevalence of high-grade cervical lesions (17%) was observed among these HIVseropositive women at baseline visit. This prevalence of HSIL is higher than that observed for HIVseropositive populations in France and French Guyana (7.5%), a 12-nation, European cohort (2.8%), Finland (5%), and Zimbabwe (3.4%) [10, [17] [18] [19] , but lower than that found for an HIV-seropositive population in Zambia (32.6%) [20] . Differences in HSIL prevalence across studies may be attributable in part to differences in HIV disease stage. Both our study population and the study group in Zambia were conducted among HIV-seropositive women with relatively lower median CD4 count (247 and 165 cells/mm 3 , respectively) than that of the 12-nation European cohort (378 cells/mm 3 ).
DISCUSSION
The lack of an association observed here for BV with high grade cervical lesions differs from the positive association found in a previous study in an HIV-seropositive population in Finland [10] , and in populations from Brazil, Holland, and South Africa, in which HIV-status was unrecorded [7] [8] [9] 14] . Our results are consistent, however, with those from two European studies with HIV status unknown [13, 15] , and three studies in the US, two with unknown HIV-status [6, 12] and one with HIV-seropositive participants [16] . Four of these studies also assessed the association between BV and HPV infection, with only one [16] finding a positive association with HPV infection [6, 12, 15] .
Although different methods were used to diagnose BV across studies (clinical diagnosis (pH >4.5, positive amine test, positive gram stain, and characteristic vaginal discharge) [9, 12, 13, 15] , gram stain [6, 16] , or from Pap slides [7, 8, 10, 14] ), in our view, the disparate association results do not appear to be explained by differences in methods to ascertain BV infection.
A high proportion of women surveyed had prevalent BV (54%). Prevalence of BV has been shown to range from 5-35% in the US and Europe, and from 18-70% in African nations [21] .
Although there is debate as to if BV is a sexually transmitted infection (STI), BV is most common in
women of reproductive age and has been associated with a higher number of reported sexual partners, the presence of other STIs, and less frequent condom use [22] . Estimates of association between BV and high grade lesions observed here was similar in the crude and multivariate analyses, suggesting that in this population, the association between BV and high grade cervical lesions is not notably confounded by shared demographic or sexual behavioral risk factors. Confounding by unmeasured factors, however, cannot be ruled out definitively.
It has been postulated that BV influences cervical lesion and cancer development both through an increase in vaginal nitrosamines and through a change in the vaginal cytokine profile [23] .
Carcinogenic nitrosamines increase the probability of DNA damage and an altered cytokine profile may reduce the immune system's ability to eliminate HPV infection. Both changes may create an environment more conducive to cancer development. HIV-seropositivity also alters vaginal immune capabilities and cytokine profiles, further complicating the etiological mechanisms suggested to link BV to cervical precancer [24] . The lack of an association between BV and high grade cervical lesions 
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